India’s Serum Institute sets human trials for corona vaccine in 6 months
New Delhi: In an exclusive interview with IANS, Adar Poonawalla, CEO, Serum Institute of India (SII), has said that SII has associated with the US-based biotechnology firm Codagenix and developed a virus-vaccine candidate which is closest to the novel coronavirus and that human trials of the vaccine are expected to start by September-October. Q: What...